OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
32
Results
Show all
Save search
Copy query
Show results for
Unknown
(32)
Publication Date
Release Date
2021
(8)
2025
(6)
2022
(6)
2017
(3)
2024
(2)
2023
(2)
2026
(1)
2020
(1)
2018
(1)
2015
(1)
2014
(1)
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
Acute effects of lactate infusion on metabolism, AD biomarkers, and cognition: The LEAN study.
Not available
S-EPMC12696042
|
biostudies-literature
Cite
Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study.
Not available
S-EPMC5719923
|
biostudies-literature
Cite
The association between childhood adversities and subsequent first onset of psychotic experiences: a cross-national analysis of 23 998 respondents from 17 countries.
Not available
S-EPMC5590103
|
biostudies-literature
Cite
Smaller Hippocampal Volume in Posttraumatic Stress Disorder: A Multisite ENIGMA-PGC Study: Subcortical Volumetry Results From Posttraumatic Stress Disorder Consortia.
Not available
S-EPMC5951719
|
biostudies-literature
Cite
Convergence of genes and cellular pathways dysregulated in autism spectrum disorders.
Not available
S-EPMC4067558
|
biostudies-literature
Cite
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic.
Not available
S-EPMC10364875
|
biostudies-literature
Cite
Identification of six new susceptibility loci for invasive epithelial ovarian cancer.
Not available
S-EPMC4445140
|
biostudies-literature
Cite
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355
|
biostudies-literature
Cite
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial.
Not available
S-EPMC8121538
|
biostudies-literature
Cite
Add-On Treatment With Zilebesiran for Inadequately Controlled Hypertension: The KARDIA-2 Randomized Clinical Trial.
Not available
S-EPMC12120674
|
biostudies-literature
Cite
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets